Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
CQceEXeEkvfGvB82